The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance
Primary Purpose
Body Weight, Insulin Resistance
Status
Completed
Phase
Phase 4
Locations
Belgium
Study Type
Interventional
Intervention
metformin
"standard diet advice"
"personal diet advice"
Sponsored by
About this trial
This is an interventional treatment trial for Body Weight
Eligibility Criteria
Inclusion Criteria: 20-55 years of age Body mass index (BMI) equal to or greater than 30 kg/m² Insulin resistance as determined by oral glucose tolerance test (OGTT) and HOMA Exclusion Criteria: Diabetes mellitus, kidney insufficiency, or hepatic insufficiency Hypogonadism with other etiology than overweight Pregnancy BMI equal to or greater than 40 kg/m²
Sites / Locations
- University Hospital Ghent
Outcomes
Primary Outcome Measures
Effect of diet on weight and insulin sensitivity/insulin resistance after 20 and 52 weeks of treatment
Secondary Outcome Measures
Effect of metformin on weight and insulin resistance after 20 and 52 weeks of treatment
Full Information
NCT ID
NCT00134290
First Posted
August 23, 2005
Last Updated
December 19, 2007
Sponsor
University Hospital, Ghent
1. Study Identification
Unique Protocol Identification Number
NCT00134290
Brief Title
The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance
Official Title
The Effects of Calorie Restriction - Whether or Not Calculated Based on BMR (Basic Metabolic Rate) - With or Without Metformin on Weight and Insulin Resistance of Obese Insulin Resistant Patients
Study Type
Interventional
2. Study Status
Record Verification Date
December 2007
Overall Recruitment Status
Completed
Study Start Date
January 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
May 2004 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
University Hospital, Ghent
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a study to:
Determine the difference between strong hypo-energetic "standard diet advice" and modest hypo-energetic "personal diet advice"; and
Determine the influence of insulin-insensitivity on obesity and weight reduction by treating patients with metformin or placebo.
Detailed Description
The aim of the present study was to determine what the difference is of a strong hypo-energetic "standard diet advice" and a modest hypo-energetic "personal diet advice" which was determined by the energy needs of a person as calculated with a combination of basal metabolic rate (BMR) and physical activity level (PAL) on weight loss and insulin sensitivity.
Secondly, this study wanted to determine what the influence is of insulin-insensitivity on obesity and weight reduction by treating the patients with metformin or placebo. The subjects were therefore randomised into two double blinded groups receiving either metformin (2 x 850 mg per day) or placebo in combination with a moderate energy restriction and a exercise regimen of 30 minutes per day for 1 year.
Treatment effects of both diets and the effect of metformin on weight reduction and insulin sensitivity were determined after a treatment period of 20 and 52 weeks.
Insulin sensitivity was quantified using the homeostasis model assessment (HOMA) and the OGTT. Body composition was determined with the bioelectrical impedance method.
Blood was also drawn for hormonal and biochemical analyses after 20 and 52 weeks of treatment. Furthermore, the patients had to fill out a 3-day food diary at baseline, after 20 weeks and after 52 weeks.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Body Weight, Insulin Resistance
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
48 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
metformin
Intervention Type
Behavioral
Intervention Name(s)
"standard diet advice"
Intervention Type
Behavioral
Intervention Name(s)
"personal diet advice"
Primary Outcome Measure Information:
Title
Effect of diet on weight and insulin sensitivity/insulin resistance after 20 and 52 weeks of treatment
Secondary Outcome Measure Information:
Title
Effect of metformin on weight and insulin resistance after 20 and 52 weeks of treatment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
20-55 years of age
Body mass index (BMI) equal to or greater than 30 kg/m²
Insulin resistance as determined by oral glucose tolerance test (OGTT) and HOMA
Exclusion Criteria:
Diabetes mellitus, kidney insufficiency, or hepatic insufficiency
Hypogonadism with other etiology than overweight
Pregnancy
BMI equal to or greater than 40 kg/m²
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mimi Giri, MD, PhD
Organizational Affiliation
University Hospital, Ghent
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Ghent
City
Ghent
ZIP/Postal Code
9000
Country
Belgium
12. IPD Sharing Statement
Links:
URL
http://www.uzgent.be
Description
Website University Hospital Ghent
Learn more about this trial
The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance
We'll reach out to this number within 24 hrs